Michael H. Baumann mostly deals with Pharmacology, Dopamine, Internal medicine, Endocrinology and Serotonin. His Pharmacology research is multidisciplinary, incorporating elements of Monoamine neurotransmitter, Neurochemical and Fenfluramine. His Dopamine study frequently links to related topics such as MDMA.
His work in the fields of Internal medicine, such as Prolactin, intersects with other areas such as Docosahexaenoic acid, Offspring and Unsaturated fatty acid. He interconnects Tyrosine kinase, In vitro and LY294002 in the investigation of issues within Endocrinology. His work on Serotonin transporter is typically connected to Iboga alkaloid as part of general Serotonin study, connecting several disciplines of science.
The scientist’s investigation covers issues in Pharmacology, Dopamine, Internal medicine, Serotonin and Endocrinology. His Pharmacology study deals with Monoamine neurotransmitter intersecting with Cathinone. The concepts of his Dopamine study are interwoven with issues in Methamphetamine and Transporter.
His research investigates the connection with Internal medicine and areas like Oncology which intersect with concerns in Head and neck squamous-cell carcinoma. His Serotonin research incorporates themes from Agonist and MDMA. His work on Neurotoxicity expands to the thematically related Endocrinology.
His primary scientific interests are in Pharmacology, Internal medicine, Oncology, Radiation therapy and Dopamine. His work carried out in the field of Pharmacology brings together such families of science as Amphetamine, Cathinone and Monoamine neurotransmitter. His research in Amphetamine intersects with topics in Biological activity and MDMA.
His studies deal with areas such as Lateralization of brain function and Neurocognitive, Cognition as well as Internal medicine. His Dopamine research includes elements of Neurochemical, Norepinephrine and Serotonin. Michael H. Baumann has included themes like Methcathinone and Potency in his Serotonin study.
His main research concerns Pharmacology, Radiation therapy, Internal medicine, Oncology and Dopamine. The various areas that he examines in his Pharmacology study include Metabolite, Dopamine receptor D2 and Opioid. His Radiation therapy research is multidisciplinary, relying on both Biomarker, Positron emission tomography, Flash and Irradiation.
His Proportional hazards model, FMISO and Hypoxia study in the realm of Internal medicine connects with subjects such as Relative Volume. The study incorporates disciplines such as Serotonin transporter and Serotonin in addition to Dopamine. His Methylone study combines topics from a wide range of disciplines, such as Transporter, MDMA, Amphetamine, Ring and Monoaminergic.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.
Richard B. Rothman;Michael H. Baumann;Christina M. Dersch;Dana V. Romero.
Diagnosis and Management of Cough Executive Summary: ACCP Evidence-Based Clinical Practice Guidelines
Richard S. Irwin;Michael H. Baumann;Donald C. Bolser;Louis Philippe Boulet.
web science (2006)
Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications.
Richard B. Rothman;Michael H. Baumann;Jason E. Savage;Laura Rauser.
Monoamine transporters and psychostimulant drugs.
Richard B. Rothman;Michael H. Baumann.
European Journal of Pharmacology (2003)
The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue
Michael H Baumann;Mario A Ayestas;John S Partilla;Jacqueline R Sink.
Depressive-Like Effects of the κ-Opioid Receptor Agonist Salvinorin A on Behavior and Neurochemistry in Rats
William A. Carlezon;Cécile Béguin;Jennifer A. DiNieri;Michael H. Baumann.
Journal of Pharmacology and Experimental Therapeutics (2006)
Powerful cocaine-like actions of 3,4-methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products.
Michael H Baumann;John S Partilla;Kurt R Lehner;Eric B Thorndike.
Hyperfractionated Accelerated Chemoradiation With Concurrent Fluorouracil-Mitomycin Is More Effective Than Dose-Escalated Hyperfractionated Accelerated Radiation Therapy Alone in Locally Advanced Head and Neck Cancer: Final Results of the Radiotherapy Cooperative Clinical Trials Group of the German Cancer Society 95-06 Prospective Randomized Trial
Volker Budach;Martin Stuschke;Wilfried Budach;Michael Baumann.
Journal of Clinical Oncology (2005)
3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings
Michael H. Baumann;Xiaoying Wang;Richard B. Rothman.
N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').
Michael H Baumann;Robert D Clark;Allison G Budzynski;John S Partilla.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: